Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Transitional Cell Carcinoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Epithelial Neoplasm
Transitional Cell Neoplasm
Transitional Cell Carcinoma

Histology

Transitional Cell Carcinoma

CI-CAN-00001613Explore in graph →

253 active trials5 approved drugs22 evidence items

NCIt: C2930
DOID: 2671
MeSH: D002295

Overview
Statistics
Survival
Genomics24
Variants & evidence22
Drugs13
Trials734
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

734 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 253
Recruiting: 125
Ph III recruiting: 17
Growth YoY: +47.5%
Industry share: 31%
Top sponsor: National Cancer Institute (NCI)
Termination share: 44%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (119)

StatusAll Active (any)Completed 208 Recruiting 162 Active Not Recruiting 98 Terminated 96 Unknown 87 Not Yet Recruiting 41 Withdrawn 32 Enrolling By Invitation 5 Available 3 Approved For Marketing 2

PhaseAll Early Phase 1 16 N/A 55 Phase 1 216 Phase 2 335 Phase 3 65 Phase 4 6

No study matches these filters